Studien

ATHOS

Telmisartan Plus HCTZ vs. Amlodipine Plus HCTZ in Older Patients With Systolic Hypertension: Results From a Large Ambulatory Blood Pressure Monitoring

ATHOS-3

Angiotensin II for the Treatment of High-Output Shock

ATIAIS

Anturane Transient Ischemic Attack Italian Study

ATIC

Anti-oxidant Therapy in Chronic renal insufficiency study

ATICH

Antifibrinolytic Therapy in acute IntraCerebral Hemorrhage

ATILA

Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion

ATIME

Quinapril Titration Interval Management Evaluation

ATLAAST

Peripheral and central blood pressure responses of combination aliskiren/hydrochlorothiazide and amlodipine monotherapy in African American patients with stage 2 hypertension

ATLANTA

Assessment of The LAtest Non-Thrombogenic Angioplasty Stent trial

ATLANTIC

A Global Study to Assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer

ATLANTIC

Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery

ATLANTIC

Angina Treatments - Lasers And Normal Therapies In Comparison

ATLANTIC DIP

Pregnancy outcome for women with pre-gestational diabetes along the Irish Atlantic seaboard. Diabetes In Pregnancy

ATLANTIS

ACE-inhibitor Trial to Lower Albuminuria in NormoTensive Insulin-dependent Subjects

ATLANTIS

Alteplase ThromboLysis for Acute Noninterventional Therapy in Ischemic Stroke

ATLANTIS

Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment

ATLANTIS

An adaptive multi-arm phase II trial of maintenance targeted therapy after chemotherapy in metastatic urothelial cancer

ATLANTIS

Anti-thrombotic strategy after trans-aortic valve implantation for aortic stenosis

ATLANTIS

AssessmenT of smalL Airways involvemeNT In aSthma

ATLANTIS-4D-CT

Anti-Thrombotic Strategy After Trans-Aortic Valve Implantation for Aortic Stenosis. The aim of this study was to determine the effects of apixaban vs standard of care on post-TAVR valve thrombosis detected by 4-dimensional (4D) computed tomography

ATLAS

A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer

ATLAS

A Study of BIIB067 When Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation

ATLAS

Acolysis during Treatment of Lesions Affecting Saphenous vein bypass grafts

ATLAS

Adjuvant Axitinib Therapy of Renal Cell Cancer in High Risk Patients

ATLAS

Adjuvant Tamoxifen: Longer Against Shorter

ATLAS

Adolescents Training and Learning to Avoid Steroids program

ATLAS

Alexander Technique Lessons, Acupuncture Sessions or usual care for patients with chronic neck pain

ATLAS

Antibiotic Treatment foLlowing surgical drAinage of perianal abscess

ATLAS

Antiretroviral Therapy as Long Acting Suppression

ATLAS

Assessment of Treatment with Lisinopril And Survival

AtLaS

Atazanavir and Lamivudine for treatment Simplification

ATLAS

Efficacy and safety of telavancin compared with vancomycin for the treatment of skin infections

ATLAS

Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma

ATLAS

Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma

ATLAS ACS 2-TIMI 51

Anti-Xa Therapy to Lower cardiovascular events in addition to Aspirin with or without thienopyridine therapy in Subjects with Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 51

ATLAS ACS TIMI 46

Anti-Xa Therapy to Lower cardiovascular events in addition to Aspirin with or without thienopyridine therapy in Subjects with Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 46

ATLAS ACS TIMI 51

Anti-Xa Therapy to Lower cardiovascular events in addition to Aspirin with or without thienopyridine therapy in Subjects with Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 51

ATLAS S-ICD

Avoid Transvenous Leads in Appropriate Subjects S-ICD

ATLAS-2M

Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults

ATLAS-A/B

A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors

ATLAS-INH

Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors

ATLAS-PPX

A Study of Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis

ATLAS4LAR

Easy Access to Smoking Cessation for People Receiving Opioid Agonist Therapy Who Are Smoking Tobacco

ATLAST

Antiplatelet Therapy versus Lovenox plus Antiplatelet therapy for patients with increased risk for Stent Thrombosis

ATLAST

Antiretroviral Trial Looking At Sex and Treatment

ATMH

Australian Trial in Mild Hypertension

ATMOSPHERE

Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE

ATN

VA/NIH Acute renal failure Trial Network

ATOCH

ATorvastatin On Chronic subdural Hematoma

ATOLL

STEMI treated with primary angioplasty and intravenous Lovenox or unfractionated heparin

ATOM

Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis

ATOM-1

Atropine for the Treatment of Myopia-1

ATOM-2

Atropine for the Treatment of Myopia-2

ATOMIC

Sofosbuvir With Pegylated Interferon and Ribavirin Hepatitis C Virus (HCV) Genotypes 1,4,5,6

ATOMIC2

A multi-centre open-label two-arm randomised superiority clinical trial of azithromycin versus usual care in ambulatory COVID-19

ATOROS

ATOrvastatin and ROSuvastatin

ATOS

A Toujeo Observational Study

ATOS

Australian Treatment Outcome Study

ATP

Adult Treatment Panel of NCEP

ATP II

Adult Treatment Panel of NCEP II